Our SPOTRIAS Program Project includes 3 clinical research subprojects, consisting of novel therapeutic interventions. All of these trials are phase 1 or 2 in their development, and have been conceptualized and designed by our group. One is brand new, and two are the next phase of projects begun during our first SPOTRIAS. The purpose of the Clinical Core is to facilitate this work. The conduct of such clinical trials is complicated requiring careful planning, expert execution, close supervision, detailed monitoring, and complex data analysis. To carry out such research requires excellent clinical facilities, ample patients, collaborative relationships and the skills of experienced investigators, nurse coordinators, and administrative staff. Special problems are inherent in conducting clinical trials that are investigator-initiated since these studies usually do not have the backing of a large funding agency or pharmaceutical company, at least in their early stages, to provide the financial and administrative support to carry out this work. The purpose of this Clinical Core is to improve the capability of orchestrating such early stage research within the Vascular Neurology (VN) Program at the University of Texas Houston Medical School. As a large, well-established Stroke Center with a thriving fellowship training program, we have been conducting investigator-initiated phase 1 and 2 clinical research for many years and have made progress with many challenges inherent in this work. The clinical collaborations, study conduct, and administration of our VN Program that evolved over its first 15 years has been substantially enhanced by the overall administrative structure, plan and central coordination provided over the past 5 years by the SPOTRIAS Clinical Core.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZNS1-SRB-G)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Health Science Center Houston
United States
Zip Code
McDonald, Mark M; Wetzel, Jeremy; Fraser, Stuart et al. (2016) Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke. J Thromb Thrombolysis 41:505-10
Lyden, Patrick; Hemmen, Thomas; Grotta, James et al. (2016) Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2). Stroke 47:2888-2895
Huang, Richard S P; McDonald, Mark M; Wetzel, Jeremy S et al. (2015) Clot Strength as Measured by Thrombelastography Correlates with Platelet Reactivity in Stroke Patients. Ann Clin Lab Sci 45:301-7
Ifejika, Nneka L; Vahidy, Farhaan; Aramburo-Maldonado, Linda A et al. (2015) Acute Intravenous Tissue Plasminogen Activator Therapy does not Impact Community Discharge after Inpatient Rehabilitation. Int J Neurorehabil 2:
Schlick, Konrad H; Hemmen, Thomas M; Lyden, Patrick D (2015) Seizures and Meperidine: Overstated and Underutilized. Ther Hypothermia Temp Manag 5:223-7
Vahidy, F S; Rahbar, M H; Lal, A P et al. (2015) Patient refusal of thrombolytic therapy for suspected acute ischemic stroke. Int J Stroke 10:882-6
Elliott, Andrea; Wetzel, Jeremy; Roper, Tiffany et al. (2015) Thromboelastography in patients with acute ischemic stroke. Int J Stroke 10:194-201
Barlinn, Kristian; Tsivgoulis, Georgios; Barreto, Andrew D et al. (2014) Outcomes following sonothrombolysis in severe acute ischemic stroke: subgroup analysis of the CLOTBUST trial. Int J Stroke 9:1006-10
Bowry, Ritvij; Fraser, Stuart; Archeval-Lao, Joancy M et al. (2014) Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke. Stroke 45:880-3
Wu, Tzu-Ching; Sitton, Clark; Potter, Andrew et al. (2014) CTP infarct core may predict poor outcome in stroke patients treated with IV t-PA. J Neurol Sci 340:165-9

Showing the most recent 10 out of 68 publications